Oncotelic Therapeutics, Inc. Investment Owned, at Fair Value
Oncotelic Therapeutics, Inc. (OTLC) had Investment Owned, at Fair Value of $388.00 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:InvestmentOwnedAtFairValue · last filed 2026-08-13
- 2026-06-30: Investment Owned, at Fair Value $388.00M.
- 2026-03-31: Investment Owned, at Fair Value $388.00M.
- 2025-12-31: Investment Owned, at Fair Value $388.00M.
- 2025-09-30: Investment Owned, at Fair Value $22.65M.
| Period end | Investment Owned, at Fair Value |
|---|---|
| 2026-06-30 | $388.00M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $388.00M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $388.00M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $22.65M 10-Q · filed 2025-11-17 |
| 2025-06-30 | $22.65M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $22.65M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $22.65M 10-K · filed 2026-04-15 |
| 2024-09-30 | $22.65M 10-Q · filed 2024-11-19 |
| 2024-06-30 | $22.65M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $22.65M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $22.65M 10-K · filed 2025-04-15 |
| 2023-09-30 | $22.64M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $22.64M 10-Q · filed 2023-08-18 |
| 2023-03-31 | $22.64M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $22.64M 10-K · filed 2024-04-12 |
| 2022-09-30 | $22.64M 10-Q · filed 2022-11-18 |